Sevelamer
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Kidney & Urinary Care treatment.
🧴 Clinical Application
Take orally with meals three times daily with a full glass of water. Typical starting dose is 800 mg to 1600 mg with each meal, titrated by 400-800 mg per meal every 2 weeks based on serum phosphorus levels (target 3.5-5.5 mg/dL). Swallow the tablet whole; do NOT chew, crush, or break, as the polymer expands in water.
⚠️ Side Effects
Common: Nausea, vomiting, diarrhea, dyspepsia, abdominal pain, constipation, flatulence. Rare/Severe: Severe bowel obstruction, ileus, fecal impaction, and intestinal perforation.
🛡️ Safety Warnings
Must be taken WITH meals to bind ingested dietary phosphate; taking on an empty stomach renders the drug ineffective. Contraindicated in bowel obstruction, ileus, and severe fecal impaction. Space other oral medications (ciprofloxacin, levothyroxine, mycophenolate) at least 1 hour before or 3 hours after sevelamer to avoid binding.
Jan Aushadhi Products containing Sevelamer
Found 2 generic formulation(s) containing this active ingredient.
Sevelamer Carbonate Tablets 400mg
Sevelamer Carbonate / Hydrochloride Tablets (400mg, 800mg) is a non-calcium, non-aluminum, non-absorbable cross-linked polymeric phosphate binder on the WHO Model List framework. In the gastrointestinal tract, its multiple amine groups become partially protonated at physiological intestinal pH, binding dietary phosphate through ionic and hydrogen bonding. The bound phosphate is excreted in the feces, decreasing intestinal phosphate absorption without releasing calcium or aluminum into the bloodstream. This prevents hypercalcemia, calciphylaxis, and metastatic vascular calcification. Indicated for the control of hyperphosphatemia in adult and pediatric patients with Chronic Kidney Disease (CKD) on hemodialysis or peritoneal dialysis, or non-dialysis CKD with serum phosphorus >= 5.5 mg/dL.
Sevelamer 800mg Tablets
Sevelamer Carbonate / Hydrochloride Tablets (400mg, 800mg) is a non-calcium, non-aluminum, non-absorbable cross-linked polymeric phosphate binder on the WHO Model List framework. In the gastrointestinal tract, its multiple amine groups become partially protonated at physiological intestinal pH, binding dietary phosphate through ionic and hydrogen bonding. The bound phosphate is excreted in the feces, decreasing intestinal phosphate absorption without releasing calcium or aluminum into the bloodstream. This prevents hypercalcemia, calciphylaxis, and metastatic vascular calcification. Indicated for the control of hyperphosphatemia in adult and pediatric patients with Chronic Kidney Disease (CKD) on hemodialysis or peritoneal dialysis, or non-dialysis CKD with serum phosphorus >= 5.5 mg/dL.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Sevelamer.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Sevelamer Carbonate Tablets 400mg | 10's | ₹51.56 | REVLAMER, PHOSCUT, SEVCAR, SEVBAIT, ACUTROL | ₹199.92 | 74% Save |
| Sevelamer 800mg Tablets | 10's | ₹75.00 | REVLAMER, SEVCAR, PHOSCUT, ACUTROL, SEVBAIT | ₹309.17 | 76% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Sevelamer generics.